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Rett syndrome (RTT; OMIM#312750) is a severe neurodevelopmental disorder that affects mainly girls.
It has an estimated incidence of 1:10 000–15 000 females. Mutations in the X-linked gene methyl CpG-
binding protein 2 (MECP2) have been found in most patients. The most accepted explanation for the sex
bias is that the Rett mutation in sporadic cases has its origin in the paternal germline X chromosome and
can thus only be transmitted to females. The majority of cases are sporadic (99.5%) but some familial cases
have been described. These cases can either be explained by germline mosaicism or by asymptomatic
carrier mothers with skewing of X-inactivation towards the wild-type MECP2 allele. We describe one of the
few familial cases of RTT in which a maternal germline mosaicism is the most likely explanation. The
mutation p.Arg270fs (c.808delC) was identified in both a girl with classical RTT and her brother who had
the severe neurological phenotype usually described in males. The mutation was absent in DNA extracted
from blood of both parents. These type of events must be taken into consideration in the genetic
counselling of families after the diagnosis of a first case of RTT in a female or a MECP2 mutation in a male.
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Introduction
Rett syndrome (RTT; OMIM#312750) is a severe neuro-
developmental disorder that affects mainly girls.1 It has an
estimated incidence of 1:10 000–15 000 females2 and is
one of the leading causes of mental retardation in this sex.3
The diagnosis is based on the established criteria defined
by Hagberg.4 Mutations in the X-linked gene methyl
CpG-binding protein 2 (MECP2) have been found in most
patients.5 Recently other genes (CDKL56 and Netrin G17)
have been linked to this disease. Male lethality and
uniparental disomy have been proposed as possible
explanations for the sex bias. The most interesting
suggestion, proposed by several authors8,9 is that the Rett
mutation in sporadic cases has its origin in the paternal
germline X chromosome and can thus only be transmitted
to females. The majority of cases are sporadic (99.5%).10
Only a few familial cases with documented MECP2
mutation have been reported. Some were explained by
skewing of X-inactivation towards the wild type allele of
MECP2 in an asymptomatic carrier. In others, five, germ-
line mosaicism (four maternal2,8,11,12 and one paternal13)
was a possible explanation.
Clinical description
Case 1
The index case is a 3-year-old girl who was referred to us
due to moderate developmental delay, severe growth
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retardation (weight, 11.010 kg (oP5), standing height,
85 cm (oP5), head circumference, 46 cm (oP5)) since
birth, and desacceleration of the head growth, ataxic gait,
and hand stereotypies since 24 months of age. The prenatal
and perinatal history was considered normal. A thorough
investigation (for chromosomal, neurological and meta-
bolic disorders) had already been performed without any
diagnostic results. In our observation, non-relevant dys-
morphisms were noted, and the diagnoses of RTT and
Angelman syndrome (AS) were considered. The molecular
study for the AS revealed a biparental pattern of methyla-
tion. The molecular analysis of MECP2 gene detected the
mutation p.Arg270fs (c.808delC) (described in the
RettBASE: IRSA MECP2 Variation Database, http://mecp2.
chw.edu.au/mecp2/), thus confirming the diagnosis of RTT.
Case 2
Her younger brother was 1-year–old when the diagnosis of
RTT was carried out after being confirmed on his sister. The
same mutation was found on the MECP2 gene. His prenatal
history was considered normal, but since early age severe
growth retardation and development delay was noted. At
birth, his somatometric parameters were within the normal
range for a 38 weeks’ gestation (weight, 2330 g (P3),
recumbent height, 44 cm (P3–10), head circumference,
32.3 cm (P10–25)) as well as his Apgar score (7 at the first
minute and 9 at the fifth minute). However, due to food
refusal, he was admitted in a neonatal intensive care unit
for a week. When he was 8 months old, his somatometric
evaluation was consistent with severe growth retardation
(weight, 5150 g (oP5), recumbent height, 60.1 cm (oP5),
head circumference, 38.3 cm (oP5)). He was hypotonic
and had very poor visual contact and facial mimic, weak
crying and repetitive oral facial and lingual movements. He
showed synophris, upslanting palpebral fissures and micro-
gnathia. His cytogenetic study was normal (46,XY). An
electroencephalogram was also performed; it revealed low
paroxistical activity at the right temporal region.
The developmental assessment, at 17 months of age,
using the Ruth Griffiths Mental Development Scales
confirmed the severe developmental delay. The overall
developmental quotient was extremely difficult to evaluate
(5%). He had a mental age corresponding to 1 month and
his functional level was below 3 months. The speech and
hearing and eye-hand tests coordination presented the
worse scores (3%). The performance, locomotor and
personal-social subscales showed a value of 6%. The
locomotor evaluation showed that when on ventral
position he could only push our hands with his feet but
not raise his head and upper body. On ventral prone, he
merely tried to rotate the head and was not able to raise it
or to pull himself into a crawl position. He could not sit
without support but held the head erect and the back
straightened for only very short periods of time. The
personal-social development revealed that he sporadically
smiled responsively and liked having bath. He felt secure
when he was held but did not try to reach the person.
Regarding the hearing and language area, his skills were
very poor (he reacted badly to loud sounds; did not turn his
head towards a sound source; and could simply make some
vocalizations). On the hand and eye coordination testing,
he sometimes followed a light horizontally, but did not
stare at or follow an object. He could not change his look
between two objects or tried to grab it in the midline. The
performance analysis showed that he reacted to paper
when it was in front of him but did not try to reach it. His
hands were more or less open and he put them sometimes
on the mouth but he was not able to hold a cube on his
hand.
He died at 21 months of age due to severe metabolic
disequilibrium during a gastrointestinal infectious disease.
The molecular analysis of MECP2 gene of their parents
peripheral blood revealed that neither of them was a carrier
for that mutation.
Conclusion
We describe one of the few familial cases of RTT, in which a
maternal germline mosaicism is the most likely explana-
tion. We have described two children of a non-carrier
couple, a girl with a classical form of RTT and a boy with a
more severe and atypical presentation.
As reviewed previously in a paper by Williamson et al,5
most RTT patients are sporadic and the recurrence risk is
low. However, maternal heterozygoty with X-inactivation
is a possibility that can be excluded by molecular studies.
Even then maternal gonadal mosaicism may exist as once
again described in this family.
The presence of the same mutation in a male sib has a
recognized phenotype difference. However, our patient has
a milder disease than expected. This should be taken into
account regarding the indication for MECP2 molecular
studies in males.
Being the proband male, the probability of a maternal
heterozygosity or germline mosaicism is greater and the
parents should be made aware of this fact.
The knowledge of the rare events described here will be
useful regarding the genetic counselling of families where a
first diagnosis of RTT in a female or MECP2 mutation in a
male is carried out.10,12
References
1 Weaving LS, Ellaway CJ, Gecz J, Christodoulou J: Rett syndrome:
clinical review and genetic update. J Med Genet 2005; 42: 1–7.
2 Wan M, Lee SS, Zhang X et al: Rett syndrome and beyond:
recurrent spontaneous and familial MECP2 mutations at CpG
hotspots. Am J Hum Genet 1999; 65: 1520–1529.
3 Gill H, Cheadle JP, Maynard J et al: Mutation analysis in the
MECP2 gene and genetic counselling for Rett syndrome. J Med
Genet 2003; 40: 380–384.
Maternal germline mosaicism in Rett syndrome
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